Biochemical and Biophysical Approaches to Probe CFTR Structure

Methods in Molecular Biology

Volumn 741, Issue , 2011, Pages 365-376

  Schmidt, André ^a   Mendoza, Juan L ^a   Thomas, Philip J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CFTR folding; CFTR structure; NBD1; spectroscopy; stability

Indexed keywords

NUCLEOTIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; ARTICLE; BIOCHEMISTRY; BIOPHYSICS; CHEMISTRY; CIRCULAR DICHROISM; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PROTEIN DENATURATION; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE; SPECTROFLUOROMETRY; TEMPERATURE; X RAY CRYSTALLOGRAPHY;

ANIMALS; BIOCHEMISTRY; BIOPHYSICS; CIRCULAR DICHROISM; CRYSTALLOGRAPHY, X-RAY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; MICE; NUCLEOTIDES; PROTEIN DENATURATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE; TEMPERATURE;

EID: 80052310354     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-117-8_24     Document Type: Chapter

References (48)

1. Kleizen, B., and Braakman, I. (2004) Protein folding and quality control in the endo-plasmic reticulum. Curr. Opin. Cell Biol. 16, 343–349.
2. Zhang, F., Kartner, N., and Lukacs, G. L. (1998) Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat. Struct. Biol. 5, 180–183.
3. Amaral, M. D. (2006) Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease. J. Inherit. Metab. Dis. 29, 477–487.
4. Wigley, W. C., Corboy, M. J., Cutler, T. D., Thibodeau, P. H., Oldan, J., Lee, M. G., et al. (2002) A protein sequence that can encode native structure by disfavoring alternate conformations. Nat. Struct. Biol. 9, 381–388.
5. Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L., and Riordan, J. R. (1995) Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129–135.
6. Ward, C. L., Omura, S., and Kopito, R. R. (1995) Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121–127.
7. Mendoza, J. L., and Thomas, P. J. (2007) Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J. Bioenerg. Biomembr. 39, 499–505.
8. Lewis, H. A., Buchanan, S. G., Burley, S. K., Conners, K., Dickey, M., Dorwart, M., et al. (2004) Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 23, 282–293.
9. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827–834.
10. Yang, Y., Janich, S., Cohn, J. A., and Wilson, J. M. (1993) The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc. Natl. Acad. Sci. USA 90, 9480–9484.
11. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761–764.
12. Brown, C. R., Hong-Brown, L. Q., Biw-ersi, J., Verkman, A. S., and Welch, W. J. (1996) Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1, 117–125.
13. Zhang, X. M., Wang, X. T., Yue, H., Leung, S. W., Thibodeau, P. H., Thomas, P. J., et al. (2003) Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 278, 51232–51242.
14. Meacham, G. C., Lu, Z., King, S., Sorscher, E., Tousson, A., and Cyr, D. M. (1999) The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18, 1492–1505.
15. Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., et al. (2006) Hsp90 cochaperone Aha1 downreg-ulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803–815.
16. Younger, J. M., Ren, H. Y., Chen, L., Fan, C. Y., Fields, A., Patterson, C., et al. (2004) A foldable CFTR{Delta}F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase. J. Biol. Chem. 167, 1075–1085.
17. Pissarra, L. S., Farinha, C. M., Xu, Z., Schmidt, A., Thibodeau, P. H., Cai, Z., et al. (2008) Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem. Biol. 15, 62–69.
18. Teem, J. L., Berger, H. A., Ostedgaard, L. S., Rich, D. P., Tsui, L. C., and Welsh, M. J. (1993) Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast. Cell 73, 335– 346.
19. Teem, J. L., Carson, M. R., and Welsh, M. J. (1996) Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing. Recept. Channels 4, 63–72.
20. Dork, T., Wulbrand, U., Richter, T., Neu-mann, T., Wolfes, H., Wulf, B., et al. (1991) Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene. Hum. Genet. 87, 441–446.
21. Dork, T., Wulbrand, U., Steinkamp, G., and Tummler, B. (1992) Mild course of cystic fibrosis associated with heterozygosity for infrequent mutations in the first nucleotide-binding fold of CFTR. Acta Paediatr. 81, 82–83.
22. Roxo-Rosa, M., Xu, Z., Schmidt, A., Neto, M., Cai, Z., Soares, C. M., et al. (2006) Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms. Proc. Natl. Acad. Sci. USA 103, 17891–17896.
23. Farinha, C. M., and Amaral, M. D. (2005) Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol. Cell. Biol. 25, 5242–5252.
24. Rosser, M. F., Grove, D. E., Chen, L., and Cyr, D. M. (2008) Assembly and misassem-bly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2. Mol. Biol. Cell 19, 4570–4579.
25. Gnann, A., Riordan, J. R., and Wolf, D. H. (2004) Cystic fibrosis transmembrane conductance regulator degradation depends on the lectins Htm1p/EDEM and the Cdc48 protein complex in yeast. Mol. Biol. Cell 15, 4125–4135.
26. Younger, J. M., Chen, L., Ren, H. Y., Rosser, M. F., Turnbull, E. L., Fan, C. Y., et al. (2006) Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126, 571–582.
27. Schmidt, B. Z., Watts, R. J., Aridor, M., and Frizzell, R. A. (2009) Cysteine string protein promotes proteasomal degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) by increasing its interaction with the C terminus of Hsp70-interacting protein and promoting CFTR ubiquitylation. J. Biol. Chem. 284, 4168–4178.
28. Du, K., Sharma, M., and Lukacs, G. L. (2005) The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat. Struct. Biol. 12, 17–25.
29. Cui, L., Aleksandrov, L., Chang, X. B., Hou, Y. X., He, L., Hegedus, T., et al. (2007) Domain interdependence in the biosynthetic assembly of CFTR. J. Mol. Biol. 365, 981– 994.
30. Kleizen, B., van Vlijmen, T., de Jonge, H. R., and Braakman, I. (2005) Folding of CFTR is predominantly cotranslational. Mol. Cell 20, 277–287.
31. Atwell, S., Brouillette, C. G., Conners, K., Emtage, S., Gheyi, T., Guggino, W. B., et al. (2010) Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant. Protein Eng. Des. Sel. 23, 375–384.
32. Lewis, H. A., Wang, C., Zhao, X., Hamuro, Y., Conners, K., Kearins, M. C., et al. (2010) Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry. J. Mol. Biol. 396, 406–430.
33. Lewis, H. A., Zhao, X., Wang, C., Sauder, J. M., Rooney, I., Noland, B. W., et al. (2005) Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J. Biol. Chem. 280, 1346–1353.
34. Thibodeau, P. H., Brautigam, C. A., Machius, M., and Thomas, P. J. (2005) Side chain and backbone contributions of Phe508 to CFTR folding. Nat. Struct. Mol. Biol. 12, 10–16.
35. Aller, S. G., Yu, J., Ward, A., Weng, Y., Chit-taboina, S., Zhuo, R., et al. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323, 1718–1722.
36. Dawson, R. J., and Locher, K. P. (2006) Structure of a bacterial multidrug ABC transporter. Nature 443, 180–185.
37. Locher, K. P., Lee, A. T., and Rees, D. C. (2002) The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296, 1091–1098.
38. Reyes, C. L., and Chang, G. (2005) Lipopolysaccharide stabilizes the crystal packing of the ABC transporter MsbA. Acta Crystallogr. 61, 655–658.
39. Kanelis, V., Hudson, R. P., Thibodeau, P. H., Thomas, P. J., and Forman-Kay, J. D. (2010) NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J. 29, 263–277.
40. Hartman, J., Huang, Z., Rado, T. A., Peng, S., Jilling, T., Muccio, D. D., et al. (1992) Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J. Biol. Chem. 267, 6455–6458.
41. Ko, Y. H., Thomas, P. J., Delannoy, M. R., and Pedersen, P. L. (1993) The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J. Biol. Chem. 268, 24330–24338.
42. Neville, D. C., Rozanas, C. R., Tulk, B. M., Townsend, R. R., and Verkman, A. S. (1998) Expression and characterization of the NBD1-R domain region of CFTR: evidence for subunit-subunit interactions. Biochemistry 37, 2401–2409.
43. Qu, B. H., and Thomas, P. J. (1996) Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway. J. Biol. Chem. 271, 7261–7264.
44. Yike, I., Ye, J., Zhang, Y., Manavalan, P., Gerken, T. A., and Dearborn, D. G. (1996) A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms. Protein Sci. 5, 89–97.
45. Chan, K. W., Csanady, L., Seto-Young, D., Nairn, A. C., and Gadsby, D. C. (2000) Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator’s NH(2)-terminal nucleotide binding domain. J. General Phys. 116, 163–180.
46. Gibson, A. L., Wagner, L. M., Collins, F. S., and Oxender, D. L. (1991) A bacterial system for investigating transport effects of cystic fibrosis-associated mutations. Science 254, 109–111.
47. Mossessova, E., and Lima, C. D. (2000) Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell 5, 865–876.
48. Hutt, D. M., Herman, D., Rodrigues, A. P., Noel, S., Pilewski, J. M., Matteson, J., et al. (2010) Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat. Chem. Biol. 6, 25–33.